Private Label Tranexamic & Kojic Acid Eye Serum Low MOQ

Can I sell a private label tranexamic acid eye serum in the EU?

By Blake Mereby · Last reviewed October 4, 2026

Yes, you can sell a private label tranexamic acid and kojic acid eye serum in the European Union, but there are specific regulatory requirements you must meet before placing the product on the EU market, and one active ingredient — kojic acid — carries a status you need to monitor closely.

The EU Cosmetics Regulation (EC) No 1223/2009 governs all cosmetic products sold in the EU. Under this framework, you must appoint a Responsible Person (RP) established within the EU — this is the legal entity responsible for the product's regulatory compliance. The RP must maintain a Product Information File (PIF) including the formula, manufacturing details, safety assessment, and stability data. They are also responsible for submitting a CPNP (Cosmetic Products Notification Portal) notification before the product goes on sale in any EU member state.

Transexamic acid is permitted as a cosmetic ingredient in the EU with no specific concentration restriction at this time, making it a straightforward active for EU market entry at the 2–3% range used in most formulas.

Kojic acid is where EU compliance becomes more complex. As of the most recent SCCS (Scientific Committee on Consumer Safety) opinions, kojic acid has been assessed and found to be of concern at concentrations above 1% in leave-on products. The EU has been moving toward restricting kojic acid in leave-on products to 1% maximum. Always verify the current status with a qualified EU regulatory consultant at the time of your launch, as the regulatory landscape for this ingredient is actively evolving. Formulating at or below 1% kojic acid provides the most defensible compliance position for EU market entry.

You will also need a Cosmetic Product Safety Report (CPSR) authored by a qualified safety assessor (typically a toxicologist) covering both the individual ingredient safety and the finished product safety. For a brightening eye serum with TXA and kojic acid, expect the safety assessor to scrutinize the kojic acid sensitization data specifically.

Labeling in the EU requires ingredient listing in INCI nomenclature in descending order of concentration, a minimum 2-year shelf life or PAO (period after opening) symbol if shelf life exceeds 30 months, and all mandatory label fields (net content, RP name and address, country of origin, product function, precautions) in the language of the country of sale.

For brands new to EU market entry, partnering with an experienced EU Responsible Person service and a cosmetic regulatory consultant before finalizing your formula is strongly recommended. AJ Cosmo Labs can connect you with formulators and regulatory partners familiar with EU brightening category requirements through the iOS app.

Ingredients in this answer: Tranexamic Acid · Kojic Acid

Read the full guide on Private Label Tranexamic & Kojic Acid Eye Serum Low MOQ →

More about Private Label Tranexamic & Kojic Acid Eye Serum Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app